SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: BD who wrote (728)2/16/1998 10:48:00 AM
From: Dr. John M. de Castro  Read Replies (1) | Respond to of 887
 
Jasman's referring to the Phase IV data. Two of the 40 patients (5%) treated with DepoCyt died of complications unrelated to DepoCyt. To my knowledge, there has never been a fatality attributable to DepoCyt. patients have died during the trials but it has occurred due to the progress of the disease and not to DepoCyt administration.

John de C